Anti-Myogenin Antibody, clone 1M17 ZooMAb^® Rabbit Monoclonal

200

rabbit

expressed in HEK 293 cells

unconjugated

purified antibody

primary antibodies

1M17, recombinant monoclonal

recombinant, expressed in HEK 293 cells

ZooMAb^® learn more

lyophilized

calculated mol wt 25.04 kDa
observed mol wt ~34 kDa

using Protein A

human

antibody small pack of 25 μL

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

recombinant expression
Learn more about Antibody Enhanced Validation

immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable

IgG

C-terminal half

NP_002470

P15173

ambient

2-8℃

ZooMAb^® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb^® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb^® antibodies are reliably available and ready to ship when you need them.

Clone 1M17 is a ZooMAb^® Rabbit recombinant monoclonal antibody that specifically detects Myogenin. It targets an epitope within 20 amino acids from the C-terminal half.

KLH-conjugated linear peptide corresponding to 20 amino acids from the C-terminal half of human Myogenin.

Quality Control Testing

Evaluated by Western Blotting in A549 cell lysate.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected Myogenin in A549 cell lysate.

Tested applications

Immunocytochemistry Analysis: A 1:1,000 dilution from a representative lot detected Myogenin in A549 cells.

Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Myogenin in human rhabdomyosarcoma tissue sections.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.

300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Myogenin (UniProt: P15173; also known as Class C basic helix-loop-helix protein 3, bHLHc3, Myogenic factor 4, Myf-4) is encoded by the MYOG (also known as BHLHC3, MYF4) gene (Gene ID: 4656) in human. Myogenin is a muscle-specific basic-helix-loop-helix (bHLH) transcription factor that is involved in the coordination of skeletal muscle development and repair. It acts as a transcriptional activator to promote transcription of muscle-specific target genes and plays a role in muscle differentiation and muscle atrophy. It is shown to be essential for the development of functional embryonic skeletal fiber muscle differentiation. However, it is dispensable for postnatal skeletal muscle growth. It facilitates cell cycle exit during terminal muscle differentiation through the up-regulation of miR-20a expression, which in turn represses genes involved in cell cycle progression. Myogenin is a homodimeric protein that can also heterodimerize with E12 and heterodimerization enhances its DNA-binding and transcriptional activities. Myogenin can be phosphorylated by CAMK2G on threonine and serine residues in a muscle activity-dependent manner. Phosphorylation of threonine 87 is reported to impair its DNA-binding and trans-activation/functions in contracting muscles. Myogenin expression has also been reported in rhabdomyosarcomas and it is used as diagnostic markers to identify the disease. This ZooMAb^® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Adhikari, A., et al. (2021). PLoS ONE 16(1): e0245618).

Recommend storage of lyophilized product at 2-8℃; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8℃, or -20℃ for long term storage. Avoid repeated freeze-thaws.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

13 - Non Combustible Solids

WGK 1